Below are the top 10 best-rated Biotech stocks, based on the percentage of
positive ratings by brokerage analysts. One Chinese company (WX) is on the list.
WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) is the first best-rated stock in
this segment of the market. It is rated positively by 100% of the 14 brokerage
analysts covering it. Curis, Inc. (NASDAQ:CRIS) is the second best-rated stock
in this segment of the market. It is rated positively by 100% of the 9 brokerage
analysts covering it. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) is the third
best-rated stock in this segment of the market. It is rated positively by 100%
of the 8 brokerage analysts covering it. Halozyme Therapeutics, Inc.
(NASDAQ:HALO) is the fourth best-rated stock in this segment of the market. It
is rated positively by 100% of the 8 brokerage analysts covering it. Keryx
Biopharmaceuticals (NASDAQ:KERX) is the fifth best-rated stock in this segment
of the market. It is rated positively by 100% of the 8 brokerage analysts
covering it. Pharmacyclics, Inc. (NASDAQ:PCYC) is the sixth best-rated stock in
this segment of the market. It is rated positively by 100% of the 8 brokerage
analysts covering it. Trius Therapeutics, Inc. (NASDAQ:TSRX) is the seventh
best-rated stock in this segment of the market. It is rated positively by 100%
of the 8 brokerage analysts covering it. Anthera Pharmaceuticals Inc
(NASDAQ:ANTH) is the eighth best-rated stock in this segment of the market. It
is rated positively by 100% of the 7 brokerage analysts covering it. BioSante
Pharmaceuticals, Inc. (NASDAQ:BPAX) is the ninth best-rated stock in this
segment of the market. It is rated positively by 100% of the 7 brokerage
analysts covering it. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) is the 10th
best-rated stock in this segment of the market. It is rated positively by 100%
of the 6 brokerage analysts covering it.
No comments:
Post a Comment